Related Experiment Video
Updated: Jan 22, 2026

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
Published on: June 8, 2020
Sequence-specific m6A demethylation in RNA by FTO fused to RCas9
Kristina Rau1, Lukas Rösner1, Andrea Rentmeister1
1Institute of Biochemistry, Department of Chemistry, University of Münster, 48149 Münster, Germany.
Abstract:
N6-methyladenosine (m6A) is the most common internal modification in eukaryotic mRNA and associated with numerous cellular processes in health and disease. Up- and down-regulation of its "writer" or "eraser" proteins alter the global m6A level; however, modifying distinct m6A sites has remained elusive. We genetically fused the dioxygenase FTO responsible for m6A demethylation to RCas9 as an RNA-targeting module. The resulting RCas9-FTO retained demethylation activity and bound to RNA in a sequence-specific manner depending on the sgRNA and PAMmer. Using SCARLET analysis, we quantified the m6A level at a specific site and analyzed the effect of the PAM-to-m6A distance on activity. Sequence-specific demethylation by RCas9-FTO was tested on different RNA combinations and showed up to 15-fold sequence preference for target RNA compared to off-target RNA. Taken together, RCas9-FTO represents a new tool for sequence-specific demethylation of m6A in RNA that can be readily adapted to any given RNA sequence and opens the door to studying the function of distinct m6A sites.
Insights
Scientists developed RCas9-FTO, a novel tool for precise RNA demethylation. This technology allows targeted removal of N6-methyladenosine (m6A) modifications at specific sites, advancing the study of m6A functions.
Area of Science:
- Molecular Biology
- Epigenetics
- RNA Modifications
Background:
- N6-methyladenosine (m6A) is a prevalent mRNA modification influencing cellular processes.
- Current methods lack precision in targeting specific m6A sites for modification.
- Modulating global m6A levels via writer/eraser proteins is insufficient for site-specific studies.
Purpose of the Study:
- To develop a tool for sequence-specific demethylation of m6A in RNA.
- To enable precise manipulation of individual m6A sites.
- To facilitate the study of distinct m6A site functions.
Main Methods:
- Genetic fusion of the m6A demethylase FTO to the RNA-targeting module RCas9.
- Utilizing sgRNA and PAMmer for sequence-specific RNA binding.
- Employing SCARLET analysis to quantify site-specific m6A levels.
- Assessing demethylation activity and sequence preference of RCas9-FTO.
Main Results:
- RCas9-FTO demonstrated sequence-specific RNA binding and retained FTO demethylation activity.
- SCARLET analysis quantified m6A levels and analyzed PAM-to-m6A distance effects.
- RCas9-FTO exhibited up to 15-fold sequence preference for target RNA.
- The tool proved adaptable to various RNA sequences.
Conclusions:
- RCas9-FTO is a novel tool for targeted RNA m6A demethylation.
- This technology allows for precise manipulation of specific m6A sites.
- RCas9-FTO opens new avenues for investigating the functional roles of distinct m6A modifications.
More Related Videos
11:04RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level
Published on: May 19, 2019
08:33Laser-Capture Microdissection RNA-Sequencing for Spatial and Temporal Tissue-Specific Gene Expression Analysis in Plants
Published on: August 5, 2020
Related Concept Videos
Reclosers and Fuses
A comprehensive protection scheme for radial distribution...
Circuit Breaker and Fuse Selection
In high-voltage systems,...
RNA Splicing
RNA Editing
RNA Stability
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...